Literature DB >> 12596105

Serum insulinlike growth factor-I in biliary atresia.

Shigehiko Yoshida1, Masaki Nio, Yutaka Hayashi, Ryoji Ohi, Ikuo Kawamura, Toshio Goto.   

Abstract

BACKGROUND/
PURPOSE: Low level of Insulinlike growth factor-I (IGF-I) has been reported in children with chronic liver disease like biliary atresia (BA) awaiting liver transplantation. However, there has been no report on IGF-I in BA managed without liver transplantation.
METHODS: The authors measured IGF-I and growth hormone (GH) in 21 postoperative BA, and 17 choledochal cysts (CC) as a control with normal liver function. To avoid an influence of aging, IGF-I was analyzed after converting them into a newly defined index "IGF%." IGF% is proportional to the lower limit of the value of IGF-I in gender- and age-matched normal control previously reported in literature.
RESULTS: IGF% in BA was significantly lower than that in CC. IGF% tended to be lower in Kasai's type III (atresia at the porta hepatis) and higher in the jaundice-free group. IGF% in patients with esophageal varices was significantly lower. The correlation between choline esterase and IGF% was positive and that for TTT and IGF% was negative.
CONCLUSIONS: Low level of IGF-I is a characteristic finding in BA, especially in patients without need of liver transplantation. And it may reflect the severity of pathologic changes (ie, hepatic fibrosis and reduced volume of normally functioning liver) in BA liver. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12596105     DOI: 10.1053/jpsu.2003.50045

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Gene expression profile of the infective murine model for biliary atresia.

Authors:  Johannes Leonhardt; Martin Stanulla; Reinhard von Wasielewski; Julia Skokowa; Joachim Kübler; Benno M Ure; Claus Petersen
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

2.  Circulating microRNA is a biomarker of biliary atresia.

Authors:  Adam M Zahm; Nicholas J Hand; LaTasha A Boateng; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-10       Impact factor: 2.839

3.  Elevated serum nitric oxide metabolites in biliary atresia.

Authors:  Paisarn Vejchapipat; Voranush Chongsrisawat; Apiradee Theamboonlers; Soottiporn Chittmittrapap; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

4.  Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.

Authors:  Orhan Tarçin; Nursal Gedik; Berna Karakoyun; Veysel Tahan; Gagan Sood; Ciğdem Celikel; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

5.  Hepatic expression of HGF/C-met and native liver survival in biliary atresia.

Authors:  Panicha Tangtrongchitr; Sopee Poomsawat; Voranush Chongsrisawat; Sittisak Honsawek; Yong Poovorawan; Yuda Chongpison; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.